The State of the Peptide Industry 2026
224 independent tests across 20 companies and 55 compounds. The industry is bifurcating, and the gap is measurable.
Institute InvestigationOath Research
Third overall in the 2026 cycle, with testing results close to the leaders and a narrower catalogue.
Independently Tested
Tests0
Score updatedSep 1, 2026
MethodologyMethodology v3.0
Movement New
Score Breakdown
Six weighted dimensions, methodology Methodology v3.0. How weights work →
- Purity & Testing 25% 93
- Product Accuracy 20% 92
- Transparency 20% 92
- Fulfillment 15% 92
- Customer Experience 10% 92
- Value 10% 91
Editorial Assessment
Oath Research placed third in the most recent cycle, with laboratory results close enough to the two companies above it that the separation comes from breadth and operational maturity rather than from product quality. A newer entrant with a narrower catalogue, which limits how much evidence we have accumulated so far, a constraint we expect to ease as sampling continues.
- Shipping & fulfillment
- Domestic dispatch with standard and expedited options.
- Policies & returns
- Returns accepted within a published window.
- Testing record
- Evaluated in the 2026 cycle. Full specimen-level testing record publishing shortly.
Independent Testing History
Testing databaseTesting record publishing shortly. Oath Research was evaluated in our most recent cycle and its Index Score™ reflects those results. The individual specimen reports behind it are being prepared for publication and will appear here.